Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 397 of 5804
-
Engineered immune cells take on childhood cancer
Disease control Recruiting nowBackground: Rhabdomyosarcoma (RMS) is a cancer of soft tissues. It is the most common soft tissue sarcoma seen in children. RMS cancer cells have a protein called FGFR4 on their surface. Researchers want to try a new kind of treatment for RMS: They will collect a person s own T …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo therapy aims to tackle tough lung cancer
Disease control Recruiting nowThis is a multi-site, open-label, dose-finding study, consisting of Parts 1, 2a, and 2b to investigate the combination of BNT326 with BNT327 in participants with relapsed, progressive as well as treatment-naïve, advanced/metastatic non-small cell lung cancer (NSCLC). This study …
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis study is an investigation to evaluate the safety/tolerability, pharmacokinetics (PK), and efficacy of GFH276 as a single agent in patients with advanced solid tumors harboring RAS mutations. The primary objectives of the Phase I study are to assess the safety/tolerability, …
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Argon gas may shield brain during neck surgery, new trial hopes
Disease control Recruiting nowCurrently, over 400,000 reconstructive surgeries on carotid arteries are performed annually worldwide, including carotid endarterectomy (CEA) and carotid stenting. These interventions have proven effective in preventing ischemic stroke in patients with hemodynamically significant…
Phase: PHASE3 • Sponsor: Negovsky Reanimatology Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Veterans with PTSD to test cannabis as a treatment for suicidal thoughts
Symptom relief Not yet recruitingThis study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.
Phase: PHASE1, PHASE2 • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New drug duo takes on tough prostate cancers
Disease control Recruiting nowThis study is a prospective, single arm II clinical trial. The main objective of the study is to evaluate the efficacy and safety of the combination of Sacituzumab Tirumotecan (SKB264) and Tagitanlimab (KL-A167) in the treatment of AVPC (aggressive variant prostate cancer) and NE…
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:44 UTC
-
Could a milk ingredient boost brain health in starving kids?
Disease control Recruiting nowThe goal of this clinical trial is to test the use of milk fat globule membrane (MFGM) in ready-to-use therapeutic food (RUTF) in children with severe acute malnutrition in Sierra Leone. The main questions it aims to answer are: * Will the inclusion of MFGM in RUTF for 6-59-mont…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a new drug clear mucus plugs in COPD lungs? trial launches.
Disease control Recruiting nowLPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compared with placebo on airway inflammation, resistance, and remodeling including mucu…
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New injection aims to shed pounds in major obesity trial
Disease control Not yet recruitingThis Phase 3 study is designed to evaluate the efficacy and safety of IN-B00009 injection in adults with obesity or overweight without diabetes mellitus
Phase: PHASE3 • Sponsor: HK inno.N Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for hard-to-treat brain cancer: combo therapy enters trial
Disease control Recruiting nowThe purpose of this phase 2 study is to evaluate the efficacy and safety of epcoritamab in subjects with relapsed or refractory primary diffuse large B-cell lymphoma of the Central Nervous System treated with rituximab and lenalidomide.
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kids' PTSD treatment uses imagination to rewrite traumatic memories
Symptom relief Recruiting nowThis study is testing a new version of a treatment called the Reconsolidation of Traumatic Memories Protocol for Children (RTM-C Protocol). The RTM Protocol™ is already proven to help adults with post-traumatic stress disorder (PTSD) by reducing distressing memories, flashbacks, …
Phase: NA • Sponsor: Viktoriia Gorbunova • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Pee test could replace painful bladder scopes for cancer patients
Diagnosis Recruiting nowNon-muscle-invasive bladder cancer (NMIBC) is usually treated with surgery to remove the tumor (transurethral resection of bladder tumor, or TURBT), often followed by bladder-instilled medications to reduce the chance of the cancer coming back. Even with this treatment, high-grad…
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo aims to shrink lung tumors before surgery in targeted trial
Disease control Not yet recruitingThis study aim to evaluate the efficacy and safety of Bozitinib combined with chemotherapy as radical treatment for stage IIA-IIIC MET-altered non-small cell lung cancer
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 26, 2026 13:39 UTC
-
Could a simple Under-the-Tongue spray protect kidneys?
Disease control Recruiting nowThis study investigates the safety and efficacy of ACE Reno, an oral transmucosal solution containing standardized bioactive peptides and amino acids, in patients with nephropathy of various etiologies and stages. The trial evaluates whether 12 weeks of ACE Reno (1 mL sublinguall…
Phase: PHASE4 • Sponsor: Ace Cells Lab Limited • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug targets Gene-Amplified breast cancers in early trial
Disease control Not yet recruitingThis study is an open-label, multicenter Phase IIa trial to evaluate the efficacy and safety of SC-101 monotherapy in patients with locally advanced or metastatic malignant tumors who are positive for NECTIN4 gene amplification.
Phase: PHASE2 • Sponsor: Tianjin ConjuStar Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:32 UTC
-
New triple therapy aims to shrink rectal tumors and avoid surgery
Disease control Not yet recruitingThis is a multicenter, prospective, phase II study evaluating total neoadjuvant therapy (TNT) consisting of short-course radiotherapy (SCRT; 5×5 Gy) followed by QL1706 (a bifunctional MabPair antibody targeting PD-1 and CTLA-4, code name only) plus mFOLFOX6 chemotherapy in patien…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 18:06 UTC
-
Hospital Gun-Safety talks could save young lives
Prevention Recruiting nowFirearm injuries are the leading cause of death for American youth. While most of these deaths are homicides, approximately one third are suicides and 5% are unintentional shootings where a child gains access to an unsecured firearm and unintentionally pulls the trigger injuring …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Could cilostazol beat aspirin at preventing strokes?
Disease control Not yet recruitingThis study is designed to evaluate whether cilostazol, an antiplatelet medication, is more effective and safer than aspirin or clopidogrel in preventing recurrent strokes and slowing disease progression in patients with cerebral small vessel disease (CSVD). Cerebral small vessel…
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Chengdu Medical College • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New Shot-Based immunotherapy combo tested for lung cancer
Disease control OngoingThe purpose of this study is to evaluate two dosing regimens of subcutaneous Nivolumab in combination with intravenous Ipilimumab and chemotherapy in participants with previously untreated metastatic or recurrent Non-Small Cell Lung Cancer (NSCLC)
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug duo targets tough pancreatic cancer in phase 2 trial
Disease control Recruiting nowThis is an open-label, multi-center phase II clinical study consisting of two parts: Part I: To evaluate the safety and efficacy of AK130 combined with AK112 in advanced pancreatic cancer. Part II: To evaluate the safety and efficacy of AK112, either as monotherapy or in combin…
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC